The microarchitecture of fossil pterosaur bones could hold the key to lighter, stronger materials for the next generation of ...

A new FDA-approved blood test is helping doctors in Texas detect colon cancer earlier. ‘The whole island has emptied:’ ...

New research shows that when an asteroid slammed into the moon billions of years ago, it carved out a pair of grand canyons ...

CAPE CANAVERAL, Fla. (AP) — New research finds an ancient asteroid strike carved out two grand canyons on the moon's far side. These aren’t the magnets you know.

In today's rapidly changing business environment, leadership and values are crucial to achieving growth. The stories of ...

Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking w.

But the citrus genus has a surprising history, popping up everywhere from ancient Rome and the Renaissance to naval exploration and Casanova's famed romantic trysts. The history of citrus dates ...

The synthetic chromosome includes features that enable researchers to generate genetic diversity on demand, accelerating the development of yeasts with enhanced capabilities for biotechnology ...

The synthetic chromosome includes features that enable researchers to generate genetic diversity on demand, accelerating the development of yeasts with enhanced capabilities for biotechnology ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...